NCBiotech News

Melissa Price, Ph.D., Heat Bio's vice president of clinical development and regulatory affairs. -- Courtesy of Heat Biologics

NCBiotech officials have doubled the Strategic Growth Loan cap from $250,000 to $500,000 for companies with exceptional chances for success -- and a solid angel or venture match.

North Carolina’s life science community can now get inside information on funding and business strategy at the NCBiotech library, via its PitchBook private equity and venture capital database.

Just two days after his company’s promising cancer-fighting technology is featured on WRAL, Raleigh’s CBS affiliate, Heat Biologics CEO Jeff Wolf is participating in a panel discussion in the North Carolina Pavilion at the BIO International Convention in San Diego.

NCBiotech Jobs Network: Working Effectively with Executive Recruiters
Blog by Ali Ghiassi, Account Manager Aerotek and Steering Committee member, NCBiotech Jobs Network

Jonathon Lawrie, Ph.D., has re-joined the North Carolina Biotechnology Center as executive director of the Western Office in Asheville, as a result of Dale Carroll’s decision to leave the post to become CEO of a newly formed regional economic development organization.

Combining efforts to look at common factors involved in Alzheimer’s and Parkinson’s disease, the Michael J. Fox Foundation for Parkinson’s Research, the Alzheimer’s Association, and The W. Garfield Weston Foundation of Canada recently announced the offering of joint research grants to help discover the similarities and differences between these neurodegenerative diseases.

Raleigh's Advanced Chemotherapy Technologies announces $5.5M in Series A to fund tests of its medical device offering targeted delivery of chemotherapy to the pancreas in humans.

Clinical data company TARGET PharmaSolutions of Chapel Hill has entered into a new strategic partnership with a major pharmaceutical company and extended existing partnerships with two others to study a serious liver disease.

PlantResponse, a plant biotechnology company based in Madrid, has established its North American headquarters in North Carolina’s Research Triangle Park and is looking for permanent facilities in the area.

Greensboro-based Piedmont Animal Health, a developer of health products for companion animals, has gained a strategic equity investment from the life science division of Sumitomo Corp., a Fortune 500 company based in Tokyo.

Raleigh-based Innovate Biopharmaceuticals has received U.S. Food and Drug Administration orphan drug designation for an experimental oral drug to treat pediatric ulcerative colitis.

The North Carolina Biotechnology Center is pleased to welcome our newest Landing Pad tenant, DAI Global Health.

The North Carolina Biotechnology Center is pleased to welcome our newest Landing Pad tenant, Fluidigm.

Clinical data company TARGET PharmaSolutions of Chapel Hill will collaborate with Dublin-based Allergan, a global pharmaceutical company, to study a major liver disease and future treatment options for it.